GBLFX
Price
$37.96
Change
-$0.24 (-0.63%)
Updated
Feb 21 closing price
Net Assets
26.01B
RIRBX
Price
$72.48
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
Ad is loading...

GBLFX vs RIRBX

Header iconGBLFX vs RIRBX Comparison
Open Charts GBLFX vs RIRBXBanner chart's image
American Funds Global Balanced F2
Price$37.96
Change-$0.24 (-0.63%)
VolumeN/A
Net Assets26.01B
American Funds Capital Income Bldr R2
Price$72.48
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
GBLFX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GBLFX vs. RIRBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBLFX is a StrongBuy and RIRBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 110B vs. GBLFX (26B). RIRBX pays higher dividends than GBLFX: RIRBX (2.55) vs GBLFX (1.84). GBLFX was incepted earlier than RIRBX: GBLFX (14 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. GBLFX (91.00). GBLFX (250) and RIRBX (250) have matching initial minimum investment requirements. RIRBX annual gain was more profitable for investors over the last year : 11.30 vs. GBLFX (5.57). RIRBX return over 5 years is better than : 24.48 vs. GBLFX (16.83).
GBLFXRIRBXGBLFX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD3.5464.98371%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets26B110B24%
Annual Yield % from dividends1.842.5572%
Returns for 1 year5.5711.3049%
Returns for 3 years7.8511.9366%
Returns for 5 years16.8324.4869%
Returns for 10 years32.4531.54103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KELYA13.870.18
+1.31%
Kelly Services
LRMR3.19-0.08
-2.45%
Larimar Therapeutics
EXPE196.81-8.33
-4.06%
Expedia Group
OSIS202.27-12.10
-5.64%
OSI Systems
SABS1.82-0.13
-6.67%
SAB Biotherapeutics